The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study за авторством Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, Ohoud Aljuhani Pharm.D, BCCCP, Ghazwa B. Korayem Pharm.D, Ali F. Altebainawi Pharm.D, Ramesh Vishwakarma PhD, Mashael AlFaifi Pharm.D, Samiah Alsohimi Pharm.D, Aljoharah Alrayes Pharm.D, Sara Albishi Pharm.D, Reem Alqahtani Pharm.D, Mai Alalawi Pharm.D, Ibrahim Al Sulaihim MSc, Thamer A. Alanazi BSc, Rahaf A. Alqahtani Pharm.D, Alaa Almagthali Pharm.D, Shahamah Jomah BSc, Areej Alshlowi BSc, Tahani R. Alshammari BSc, Shahad S. Alzahrani Pharm.D, Marwa I. Abdulqader Pharm.D

Отримати повний текст